CIA
WTM
MDAI
MDXG

Peter M. Carlson

Known title: DirectorCIK: 0001379320

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

Rising Treasury Yields Impact U.S. Insurance Stocks Including CIA. Recent increases in Treasury yields are reshaping the outlook for U.S. insurance companies, including Citizens Inc. This macroeconomic shift affects how insurers price risk and manage their investment portfolios. While the stock is currently trading near its support level, the broader industry trend driven by interest rates remains the primary factor influencing its near-term movement.

this person other insiders at CIA

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

White Mountains Upgraded by Analyst Amid Recent Trading Activity. A rating upgrade for White Mountains Insurance Group was issued, moving the stock to a Buy designation from the prior rating. The upgrade reflects renewed analyst confidence in the company's outlook. The stock is currently trading well above its identified support level of $2160.43, suggesting recent price action has already strengthened from recent lows. With a trailing P/E of 4.9, the valuation remains low relative to broader market averages.

this person other insiders at WTM

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

Spectral AI to Present Burn Wound Imaging Data at ACS 2026. Spectral AI announced it will present data on using artificial intelligence and multi-spectral imaging to assess burn wounds at the ACS Clinical Congress 2026. This event highlights the company's ongoing clinical validation efforts for its medical device technology. The stock is currently trading near its support level, with analyst targets set significantly higher than the recent price range.

this person other insiders at MDAI

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

MiMedx Wins Favorable Court Ruling on AXIOFILL Classification. A U.S. federal court ruled that MiMedx’s product AXIOFILL is not subject to the FDA’s regulatory classification that had limited its use. The decision removes a major regulatory hurdle for the company’s regenerative medicine line. The ruling could improve market perception and support future sales. The stock is currently near its 12‑month support level.

this person other insiders at MDXG

Transaction History

CIA▲ Buy—
WTM▲ Buy$0
WTM▲ Buy$0
WTM▲ Buy$0
MDAI▲ Buy$51K
WTM▲ Buy$0
MDXG▼ Sell$35K
MDXG▼ Sell$23K
MDXG▼ Sell$20K
MDXG▲ Buy$649K
MDXG▼ Sell$51K
MDXG▼ Sell$85K
MDXG▼ Sell$14K
WTM▼ Sell$280K
WTM▲ Buy$0
MDXG▲ Buy$866K
MDXG▼ Sell$52K
MDXG▼ Sell$84K

We use analytics to understand how market-wall is used. No personal data is sold.